Effect of treatment withL-dopa/carbidopa orL-selegiline on striatal dopamine transporter SPECT imaging with [123I]?-CIT
- 1 May 1999
- journal article
- clinical trial
- Published by Wiley in Movement Disorders
- Vol. 14 (3) , 436-442
- https://doi.org/10.1002/1531-8257(199905)14:3<436::aid-mds1008>3.0.co;2-j
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- [sup 123 I] beta-CIT/SPECT imaging demonstrates bilateral loss of dopamine transporters in hemi-Parkinson's diseaseNeurology, 1996
- Single photon emission computed tomographic imaging demonstrates loss of striatal dopamine transporters in Parkinson disease.Proceedings of the National Academy of Sciences, 1993
- From synapse to vesicle: The reuptake and storage of biogenic amine neurotransmittersBiochimica et Biophysica Acta (BBA) - Bioenergetics, 1993
- Positron emission tomographic imaging of the dopamine transporter with 11C‐WIN 35,428 reveals marked declines in mild Parkinson's diseaseAnnals of Neurology, 1993
- Functional imaging in relation to parkinsonian syndromesJournal of the Neurological Sciences, 1993
- Severe depletion of cocaine recognition sites associated with the dopamine transporter in Parkinson's‐diseased striatumSynapse, 1991
- The Nigrostriatal Dopaminergic System Assessed In Vivo by Positron Emission Tomography in Healthy Volunteer Subjects and Patients With Parkinson's DiseaseArchives of Neurology, 1990
- Uneven Pattern of Dopamine Loss in the Striatum of Patients with Idiopathic Parkinson's DiseaseNew England Journal of Medicine, 1988
- Positron emission tomography after MPTP: observations relating to the cause of Parkinson's diseaseNature, 1985
- Brain dopamine and the syndromes of Parkinson and Huntington Clinical, morphological and neurochemical correlationsJournal of the Neurological Sciences, 1973